Botanix Pharmaceuticals

Last updated: October 12, 2024

Matthew Callahan, Founder and CEO
Matthew Callahan, Founder and CEO
Australia | Funding: $62.4M (+)

Website: http://www.botanixpharma.com/

Botanix Pharmaceuticals intends to improve the lives of patients suffering from serious skin diseases including acne, psoriasis and atopic dermatitis using a novel therapeutic and advanced transdermal drug delivery system.